Grifols International, S.A.

Image of the headquarters of Grifols in Latin AmericaLatin America:

The Latin American region is coordinated from Grifols International headquarters, where all sales and marketing actions are determined for all the products that are distributed and the services that are offered in the region.

Grifols is firmly implanted in Latin America since 1991 with five fully owned branches and a network of highly qualified distributors.  This structure allows us to maintain close contact with healthcare professionals in communities spread across all the different countries in the Latin American area.

Grifols branches are located in the following countries and cover different geographical regions:


Parc empresarial Can Sant Joan
Av. de la Generalitat, 152
08174 Sant Cugat del Vallès
Barcelona. Spain
Tel.: [34] 935 710 500
Fax.: [34] 935 710 267


FDA approves Grifols Prolastin®-C Liquid [alpha-1 proteinase inhibitor, liquid] for the treatment of alpha-1 antitrypsin deficiency Prolastin®-C Liquid is the first liquid formulation of an alpha-1 antitrypsin deficiency replacement therapy manufactured in the U.S. The new formulation marks an important milestone in Grifols' ongoing R&D efforts
+ info

Grifols research lines in Alzheimer's move forward with both treatment and prevention Grifols has been supporting Alzheimer's research since 2004
+ info